Filing Details

Accession Number:
0001179110-10-015524
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-03 15:08:24
Reporting Period:
2010-11-02
Filing Date:
2010-11-03
Accepted Time:
2010-11-03 15:08:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274057 Hospira Inc HSP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1372882 E Thomas Werner C/O Hospira, Inc.
275 North Field Drive
Lake Forest IL 60045
Svp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-02 40,000 $39.97 53,216 No 4 M Direct
Common Stock Disposition 2010-11-02 40,000 $59.50 13,216 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2010-11-02 40,000 $0.00 40,000 $39.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2009-05-15 2014-05-15 No 4 M Direct
Footnotes
  1. The price listed is the weighted average sale price. The actual sales prices for these shares ranged between $59.445 and $59.52. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or a security holder of the issuer.